Despite our best efforts, clinical trial execution remains stubbornly unpredictable, with delays and budget overruns threatening even the most promising programs. But biotech leaders can now access a proven framework for tackling this universal challenge through RA Capital's Gateway platform and RA Capital’s website.

On the occasion of a documentary about living with cystic fibrosis and the drug that turned his life around, Gunnar Esiason reflects on his personal struggle, the roles of patients and their caregivers in drug development, and the scientific struggle we so rarely see publicly depicted.